E
Edythe D. London
Researcher at University of California, Los Angeles
Publications - 492
Citations - 36481
Edythe D. London is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Nicotinic agonist & Methamphetamine. The author has an hindex of 93, co-authored 482 publications receiving 33741 citations. Previous affiliations of Edythe D. London include Icahn School of Medicine at Mount Sinai & Semel Institute for Neuroscience and Human Behavior.
Papers
More filters
Journal Article
Program for PET image alignment: effects on calculated differences in cerebral metabolic rates for glucose.
TL;DR: A program was developed to align positron emission tomography images from multiple studies on the same subject, finding that image alignment within 2.8 mm was essential to reduce variability of measured cerebral metabolic rates for glucose.
Journal Article
Interactions between verapamil and morphine on physiological parameters in rats.
TL;DR: The authors conclude that the interaction of verapamil with morphine's respiratory depressant effects differs from the previously reported potentiation of morphine's antinociceptive and hypothermic actions.
Journal ArticleDOI
Mixture models of delay discounting and smoking behavior
Andre Hofmeyr,John Monterosso,Andy C. Dean,Angelica M. Morales,Robert M. Bilder,Fred W. Sabb,Edythe D. London +6 more
TL;DR: The results inform the interpretation of steep discounting among smokers and suggest that treatment approaches could be tailored to the type of discounting behavior that smokers exhibit.
Journal ArticleDOI
The Cardiovascular and Subjective Effects of Methamphetamine Combined with γ-vinyl-γ-aminobutyric acid (GVG) in Non-Treatment Seeking Methamphetamine-dependent Volunteers
Richard De La Garza,Todd Zorick,Keith G. Heinzerling,S. Nusinowitz,Edythe D. London,Steven Shoptaw,David E. Moody,Thomas F. Newton +7 more
TL;DR: Gamma-vinyl-gamma-aminobutyric acid (GVG) treatment is generally well tolerated but not efficacious in attenuating the positive subjective effects of methamphetamine in the laboratory, and pharmacokinetic data indicate that GVG treatment did not alter methamphetamine or amphetamine plasma levels, and there was no association between methamphetamine or Amphetamine Plasma levels and peak cardiovascular effects.
Journal ArticleDOI
Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys.
Svetlana I. Chefer,Alane S. Kimes,John A. Matochik,Andrew G. Horti,Varughese Kurian,Dean Shumway,Edward F. Domino,Edythe D. London,Alexey G. Mukhin +8 more
TL;DR: The findings suggest that the fractional occupancy of receptors by endogenous dopamine in the lesioned putamen is nearly equal to that in the contralateral putamen, and the absolute number of receptors occupied by dopamine is greater in theLesioned than in the ContralateralPutamen.